HLB Pep Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
89
- Stock Symbol
-
196300
- Investments
-
1
- Share Price
-
$2.34
- (As of Monday Closing)
HLB Pep General Information
Description
HLB Pep Co Ltd is engaged in peptide biomaterials and new drug development.
Contact Information
Website
www.hlbpep.co.krCorporate Office
- Rm.206, Pilot plant, Gwangju Technopark
- 333, Cheomdangwagi-ro, Buk-gu
- Jeonnam-Gwangju, 61008
- South Korea
Corporate Office
- Rm.206, Pilot plant, Gwangju Technopark
- 333, Cheomdangwagi-ro, Buk-gu
- Jeonnam-Gwangju, 61008
- South Korea
HLB Pep Timeline
HLB Pep Stock Performance
As of 16-Nov-2026, HLB Pep’s stock price is $2.34. Its current market cap is $22M with 9.4M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.34 | $2.51 | $2.20 - $6.58 | $22M | 9.4M | 29.7K | -$0.08 |
HLB Pep Financials Summary
As of 30-Sep-2026, HLB Pep has a trailing 12-month revenue of $3.89M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 26,665 | 31,444 | 52,728 | 71,655 |
| Revenue | 3,886 | 3,486 | 4,565 | 4,291 |
| EBITDA | 3,015 | 2,758 | (2,869) | (4,138) |
| Net Income | (997) | (451) | (4,979) | (6,944) |
| Total Assets | 36,278 | 37,366 | 11,214 | 16,292 |
| Total Debt | 13,972 | 11,737 | 5,370 | 5,702 |
HLB Pep Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
HLB Pep Patents
HLB Pep Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250109170-A1 | Method for manufacturing ganirelix | Pending | 01-Dec-2021 | ||
| WO-2023101490-A1 | Novel method for manufacturing ganirelix | Inactive | 01-Dec-2021 | ||
| WO-2023090935-A1 | Method for producing agm peptides that bind specifically to nucleolin | Inactive | 18-Nov-2021 | ||
| JP-2024517582-A | Composition for preventing or treating inflammatory bowel disease containing a novel compound | Active | 09-Sep-2021 | ||
| JP-7627783-B2 | Composition for preventing or treating inflammatory bowel disease containing a novel compound | Active | 09-Sep-2021 | C07K5/1024 |
HLB Pep Signals
HLB Pep Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
HLB Pep Investments (1)
HLB Pep’s most recent deal was a Corporate Asset Purchase with Dongyoon Seon (8,218.9 Square Meter Portfolio of Land and Building in Cheongju, South Korea) for . The deal was made on 21-Feb-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dongyoon Seon (8,218.9 Square Meter Portfolio of Land and Building in Cheongju, South Korea) | 21-Feb-2017 | Corporate Asset Purchase | Buildings and Property |
HLB Pep ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
HLB Pep FAQs
-
When was HLB Pep founded?
HLB Pep was founded in 2000.
-
Where is HLB Pep headquartered?
HLB Pep is headquartered in Jeonnam-Gwangju, South Korea.
-
What is the size of HLB Pep?
HLB Pep has 89 total employees.
-
What industry is HLB Pep in?
HLB Pep’s primary industry is Drug Discovery.
-
Is HLB Pep a private or public company?
HLB Pep is a Public company.
-
What is HLB Pep’s stock symbol?
The ticker symbol for HLB Pep is 196300.
-
What is the current stock price of HLB Pep?
As of 16-Nov-2026 the stock price of HLB Pep is $2.34.
-
What is the current market cap of HLB Pep?
The current market capitalization of HLB Pep is $22M.
-
What is HLB Pep’s current revenue?
The trailing twelve month revenue for HLB Pep is $3.89M.
-
What is HLB Pep’s annual earnings per share (EPS)?
HLB Pep’s EPS for 12 months was -$0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process